In addition, PDL1+ expression in a subset of EBV + DLBCL displayed inferior clinical outcome compared with PDL1− cases, suggesting a mechanism for immune evasion through PDL1 to underlie the worst outcome of EBV + DLBCL [81,82]. Here, CD274 is linked to diffuse large B-cell lymphoma.